Andrew D. Weinberg

Person

Portland, OR, US

People

Patents Grantslast 30 patents

Information Patent Grant
Utilization of CD39 and CD103 for identification of human tumor rea...
- Patent number 11,572,541
- Issue date Feb 7, 2023
- PROVIDENCE HEALTH & SERVICES-OREGON
- Andrew D. Weinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer treatment and monitoring methods using OX40 agonists
- Patent number 9,828,432
- Issue date Nov 28, 2017
- PROVIDENCE HEALTH & SERVICES—OREGON
- Brendan Curti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Trimeric OX40-immunoglobulin fusion protein and methods of use
- Patent number 7,959,925
- Issue date Jun 14, 2011
- Providence Health System
- Andrew D. Weinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for using OX-40 ligand to enhance an antigen specific immun...
- Patent number 7,622,444
- Issue date Nov 24, 2009
- Sisters of Providence in Oregon
- Andrew D. Weinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for enhancing antigen-specific immune response using antibo...
- Patent number 7,504,101
- Issue date Mar 17, 2009
- Sisters of Providence in Oregon
- Andrew D. Weinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T-cell antigens, and their use in diagnosis and treatment of T-cell...
- Patent number 6,566,082
- Issue date May 20, 2003
- Andrew D. Weinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for enhancing an antigen specific immune response with OX-40L
- Patent number 6,312,700
- Issue date Nov 6, 2001
- Andrew D. Weinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CD4 T-cell mediated conditions
- Patent number 5,759,546
- Issue date Jun 2, 1998
- Andrew D. Weinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CXCR5, PD-1, AND ICOS EXPRESSING TUMOR REACTIVE CD4 T CELLS AND THE...
- Publication number 20240277842
- Publication date Aug 22, 2024
- Providence Health & Services - Oregon
- Andrew D. Weinberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UTILIZATION OF CD39 AND CD103 FOR IDENTIFICATION OF HUMAN TUMOR REA...
- Publication number 20230220340
- Publication date Jul 13, 2023
- Providence Health & Services - Oregon
- Andrew D. Weinberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Anti-CD55 Antibodies and Related Compositions and Methods
- Publication number 20220088193
- Publication date Mar 24, 2022
- AgonOx, Inc.
- Ryan D. Montler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD55-Binding Agent-Related Methods and Compositions
- Publication number 20210070858
- Publication date Mar 11, 2021
- AgonOx, Inc.
- Ryan D. Montler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UTILIZATION OF CD39 AND CD103 FOR IDENTIFICATION OF HUMAN TUMOR REA...
- Publication number 20200149008
- Publication date May 14, 2020
- Providence Health & Services - Oregon
- Andrew D. Weinberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DUAL OX40 AGONIST/IL-2 CANCER THERAPY METHODS
- Publication number 20150157710
- Publication date Jun 11, 2015
- Providence Health & Services - Oregon d/b/a Providence Portland Medical Center
- William Redmond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER TREATMENT AND MONITORING METHODS USING OX40 AGONISTS
- Publication number 20150098942
- Publication date Apr 9, 2015
- Providence Health & Services - Oregon d/b/a Providence Portland Medical Center
- Brendan Curti
- G01 - MEASURING TESTING
Information Patent Application
TRIMERIC OX40-IMMUNOGLOBULIN FUSION PROTEIN AND METHODS OF USE
- Publication number 20100136032
- Publication date Jun 3, 2010
- Providence Health System
- Andrew D. Weinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for enhancing antigen-specific immune resp...
- Publication number 20070207159
- Publication date Sep 6, 2007
- Sisters of Providence in Oregon Doing Business as Providence Portland Medical...
- Andrew D. Weinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Trimeric OX40-immunoglobulin fusion protein and methods of use
- Publication number 20060280728
- Publication date Dec 14, 2006
- Providence Health System
- Andrew D. Weinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for enhancing antigen-specific immune resp...
- Publication number 20020054873
- Publication date May 9, 2002
- Andrew D. Weinberg
- C07 - ORGANIC CHEMISTRY

Andrew D. Weinberg

Person

Patents Grantslast 30 patents

Utilization of CD39 and CD103 for identification of human tumor rea...

Cancer treatment and monitoring methods using OX40 agonists

Trimeric OX40-immunoglobulin fusion protein and methods of use

Methods for using OX-40 ligand to enhance an antigen specific immun...

Methods for enhancing antigen-specific immune response using antibo...

T-cell antigens, and their use in diagnosis and treatment of T-cell...

Method for enhancing an antigen specific immune response with OX-40L

Treatment of CD4 T-cell mediated conditions

Patents Applicationslast 30 patents

CXCR5, PD-1, AND ICOS EXPRESSING TUMOR REACTIVE CD4 T CELLS AND THE...

UTILIZATION OF CD39 AND CD103 FOR IDENTIFICATION OF HUMAN TUMOR REA...

Anti-CD55 Antibodies and Related Compositions and Methods

CD55-Binding Agent-Related Methods and Compositions

UTILIZATION OF CD39 AND CD103 FOR IDENTIFICATION OF HUMAN TUMOR REA...

DUAL OX40 AGONIST/IL-2 CANCER THERAPY METHODS

CANCER TREATMENT AND MONITORING METHODS USING OX40 AGONISTS

TRIMERIC OX40-IMMUNOGLOBULIN FUSION PROTEIN AND METHODS OF USE

Compositions and methods for enhancing antigen-specific immune resp...

Trimeric OX40-immunoglobulin fusion protein and methods of use

Compositions and methods for enhancing antigen-specific immune resp...